AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RECCE PHARMACEUTICALS LTD

0.600

+0.0203.45%

Volume:37.63K

Turnover:22.48K

Market Cap:173.51M

PE:-6.64

High:0.600

Open:0.595

Low:0.595

Close:0.580

52wk High:0.730

52wk Low:0.275

Shares:289.18M

Float Shares:168.89M

Volume Ratio:0.73

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.090

EPS(LYR):-0.090

ROE:-1277.62%

ROA:-135.80%

PB:-56.85

PE(LYR):-6.64

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BUZZ-Australia's Reece Pharmaceuticals rises on research and development deal with US Army

BRIEF-Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development Agreement

Recce Pharmaceuticals Enters Into Research Agreement With US Army Institute of Surgical Research

MT Newswires Live

Recce Pharmaceuticals Ltd-Recce Enters Second U.S. Department of Defense R&D Agreement

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RCE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RCE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","market":"AU","secType":"STK","nameCN":"RECCE PHARMACEUTICALS LTD","latestPrice":0.6,"timestamp":1770697604586,"preClose":0.58,"halted":0,"volume":37626,"delay":0,"changeRate":0.03448275862068969,"nameEN":"RECCE PHARMACEUTICALS LTD","floatShares":168893037,"shares":289183422,"eps":-0.090423,"marketStatus":"Trading","change":0.02,"latestTime":"02-10 15:29:41 AEDT","open":0.595,"high":0.6,"low":0.595,"amount":22480,"amplitude":0.008621,"askPrice":0.605,"askSize":836,"bidPrice":0.595,"bidSize":20453,"shortable":3,"etf":0,"ttmEps":-0.090423,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.58,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.731485,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RCE.AU\",,,,,undefined,":{"symbol":"RCE.AU","floatShares":168893037,"roa":"-135.80%","roe":"-1277.62%","lyrEps":-0.090423,"volumeRatio":0.731485,"shares":289183422,"dividePrice":0,"high":0.6,"amplitude":0.008621,"preClose":0.58,"low":0.595,"week52Low":0.275,"pbRate":"-56.85","psRate":"23.11","week52High":0.73,"institutionHeld":0,"latestPrice":0.6,"committee":0.921462,"eps":-0.090423,"divideRate":0,"volume":37626,"delay":0,"ttmEps":-0.090423,"open":0.595,"prevYearClose":0.65,"prevWeekClose":0.57,"prevMonthClose":0.56,"prevQuarterClose":0.65,"fiveDayClose":0.6,"twentyDayClose":0.66,"sixtyDayClose":0.43,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RCE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-04-15","symbol":"RCE.AU","defaultRemindTime":1744675200000,"type":"split","dateTimestamp":1744639200000,"forFactor":990476,"toFactor":1000000,"ratio":0.990476}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RCE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RCE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608883145","title":"BUZZ-Australia's Reece Pharmaceuticals rises on research and development deal with US Army","url":"https://stock-news.laohu8.com/highlight/detail?id=2608883145","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608883145?lang=en_us&edition=fundamental","pubTime":"2026-02-02 12:14","pubTimestamp":1770005675,"startTime":"0","endTime":"0","summary":"BUZZ-Australia'sReece Pharmaceuticals rises on research and development deal with US Army** Shares of Australia's Recce Pharmaceuticals RCE.AX rise as much as 8.9% to A$0.61 ** Stock on track for its best session since December 3, 2025, if gains hold** Stock saps a four-session losing streak, and last up 3.6%** The pharmaceutical co signs a second cooperative research and development agreement with the U.S. Army Institute of Surgical Research** Agreement to conduct study to evaluate effectiveness of RECCE 327 gel in reducing bioburden burn wounds** Stock is down 10.8%, YTD   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nL6N3YY09C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","RCE.AU"],"gpt_icon":0},{"id":"2608833153","title":"BRIEF-Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608833153","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608833153?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:56","pubTimestamp":1769997414,"startTime":"0","endTime":"0","summary":"BRIEF-Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development AgreementFeb 2  - Recce Pharmaceuticals Ltd RCE.AX:RECCE ENTERS SECOND U.S. DEPARTMENT OF DEFENSE RESEARCH AND DEVELOPMENT AGREEMENTAGREEMENT TO ADVANCE RECCE 327 GEL FOR BURN WOUNDSFurther company coverage: RCE.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUE8F1KGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCE.AU","BK7096"],"gpt_icon":0},{"id":"2608882648","title":"Recce Pharmaceuticals Enters Into Research Agreement With US Army Institute of Surgical Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2608882648","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608882648?lang=en_us&edition=fundamental","pubTime":"2026-02-02 07:06","pubTimestamp":1769987208,"startTime":"0","endTime":"0","summary":"Recce Pharmaceuticals  entered into a cooperative research and development agreement with the United States Army Institute of Surgical Research to evaluate its RECCE 327 gel therapy candidate in their validated Walker-Mason rat model of burn wound infection, according to a Monday Australian bourse filing.The study will evaluate whether the gel can significantly reduce bacterial burden in infected burn wounds against methicillin-resistant bacterial pathogens, Staphylococcus aureus and Pseudomonas aeruginosa.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RCE.AU","BK7096"],"gpt_icon":0},{"id":"2608884999","title":"Recce Pharmaceuticals Ltd-Recce Enters Second U.S. Department of Defense R&D Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608884999?lang=en_us&edition=fundamental","pubTime":"2026-02-02 05:58","pubTimestamp":1769983121,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nTUE8F1KGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","RCE.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RCE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}